Progyny, Inc.
Company Stats
- Market Cap
- $1.9B
- as of Sep 30, 2026
- Shares Outstanding
- 76.7M
- Free Float
- 68.9%
Income Statement
- Revenue
- $1.3B
- Operating Income
- $85.3M
- Net Income
- $58.5M
- EBITDA
- $90.2M
- Revenue Growth, 3Y
- 17.9%
- FCF Margin, 3Y Avg
- 15.6%
- FCF Margin, Worst Year
- 14.9%
Cash Flow
- Free Cash Flow
- $191.8M
- FCF Yield
- 9.9%
- Owner FCF Yield
- 3.1%
Balance Sheet
- Cash & Equivalents
- $112.2M
Returns & Capital
- Share Repurchases
- $81.7M
- Buyback Yield, 3Y Avg
- 6.6%
- SBC, 3Y Avg
- $127.5M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $1.3B | $191.8M | 14.9% |
| FY2024 | $1.2B | $173.7M | 14.9% |
| FY2023 | $1.1B | $185.2M | 17.0% |
| FY2022 | $786.9M | $77.2M | 9.8% |
| FY2021 | $500.6M | $23.9M | 4.8% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 12, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back